文献速递血管炎

磁共振成像监测接受超短程糖皮质激素联合托珠单抗治疗巨细胞动脉炎的疾病活动度

Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在GUSTO试验的18例新诊断巨细胞动脉炎患者中,于基线及第24、52、104周行颅脑、胸腹MRI,评估血管与肌肉骨骼炎症。颅脑血管炎性表现在第52周后完全消失,而大血管(除升主动脉外)及风湿性多肌痛(PMR)表现持续存在,提示颅脑MRI或可用于监测疾病活动度和发现52周后复发。

要点

  • 颅脑血管炎性表现在第24周仍有约四分之一节段可检出,第52周及第104周均无 vasculitic 表现
  • 大血管(除升主动脉外)及PMR的炎症表现随时间几乎无减少
  • 颅脑血管信号动态变化提示颅脑MRI或可作为监测疾病活动度和发现52周后复发的潜在诊断工具

核心结论

  • 颅脑血管炎性表现在治疗52周后恢复正常,而大血管及PMR表现尽管持续完全缓解仍持续存在。
  • 颅脑血管信号的动态变化提示这些动脉的MRI或可作为监测疾病活动度和发现52周后复发的潜在诊断工具。

研究设计与样本

  • GUSTO试验中18例新诊断巨细胞动脉炎患者接受静脉甲泼尼龙500 mg连续3天,自第3天起至第52周接受托珠单抗单药治疗。
  • 于基线(活动性新发疾病)及第24、52周(治疗中缓解)和第104周(停治疗后缓解)行颅脑、胸腹MRI检查。
  • 评估PMR典型MRI表现及血管炎病变范围和严重程度。
  • 共分析18例患者的55次胸腹MRI(673个血管节段和943个肌肉骨骼区域)及49次颅脑MRI(490个血管节段)。

主要发现

  • 第24周时约四分之一颅脑节段仍可检出血管炎性血管。
  • 第52周和第104周时无颅脑血管节段显示血管炎表现。
  • 大血管(除升主动脉外)和PMR的炎症表现随时间几乎无减少。

关键数值与推荐

  • 第24周时约四分之一颅脑节段仍可检出血管炎性血管;第52周和第104周时无颅脑血管节段显示血管炎表现。
  • 大血管(除升主动脉外)和PMR的炎症表现随时间几乎无减少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: MRI is well established for diagnosing GCA. Its role in monitoring disease activity has yet to be determined. We investigated vascular and musculoskeletal inflammation using MRI in the patients of the GUSTO trial to assess the utility of MRI in monitoring disease activity. METHODS: Eighteen patients with newly diagnosed GCA received 500 mg methylprednisolone intravenously for three consecutive days followed by tocilizumab monotherapy from day 3 until week 52. Cranial, thoracic and abdominal MRI exams were performed at baseline (active, new-onset disease), and at weeks 24, 52 (remission on-treatment) and 104 (remission off-treatment). MRI findings typical for PMR as well as extent and severity of vasculitic disease were rated. RESULTS: In total, 673 vascular segments and 943 musculoskeletal regions in 55 thoracic/abdominal MRI and 490 vascular segments in 49 cranial MRI scans of 18 patients were analysed. Vasculitic vessels were still detectable in one in four cranial segments at week 24. At weeks 52 and 104, no cranial vascular segment showed a vasculitic manifestation. Large vessels, except for the ascending aorta, and PMR displayed little or no decrease in inflammatory findings over time. CONCLUSION: Vasculitic manifestations in the cranial vessels normalized after 52 weeks of treatment, whereas large vessel and PMR findings persisted despite lasting full remission. The dynamics of cranial vessel signals suggest that MRI of these arteries might qualify as a potential diagnostic tool for monitoring disease activity and for detecting relapse after 52 weeks of treatment.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Christ L, Bonel HM, Cullmann JL, et al. Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab. Rheumatology (Oxford). 2025. PMID: 39037916. doi:10.1093/rheumatology/keae378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。